Andreas Jenne
Founder bij SciRhom GmbH
Profiel
Andreas Jenne is a serial entrepreneur with more than 20 years of executive management experience in the life sciences industry.
He is currently managing director of SciRhom, a biotech start-up developing antibodies for the treatment of autoimmune diseases.
His career includes CEO positions at Kinaxo Biotechnologies (a proteomics service provider sold to Evotec in 2011), NEO New Oncology (a cancer diagnostics company acquired by Siemens Healthcare in 2016), and RSP Systems, a medical device company focusing on non-invasive diagnostics.
Andreas holds a PhD in chemistry from the Ludwig-Maximilians-University in Munich.
Actieve functies van Andreas Jenne
| Bedrijven | Functie | Begin |
|---|---|---|
SciRhom GmbH
 SciRhom GmbH Miscellaneous Commercial ServicesCommercial Services SciRhom GmbH engages in the development of treatment for life-threatening diseases. The company was founded by Andreas Jenne, Jens Ruhein, Axel Ullrich, Carl Blobel and Matthias Schneider in 2016 and is headquartered in Planegg, Germany. | Founder | 01-01-2016 |
Eerdere bekende functies van Andreas Jenne
| Bedrijven | Functie | Einde |
|---|---|---|
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Private Equity Investor | 30-09-2022 |
RSP Systems A/S
 RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark | Chief Executive Officer | 31-01-2020 |
NEO New Oncology GmbH
 NEO New Oncology GmbH Medical/Nursing ServicesHealth Services NEO New Oncology GmbH provides molecular diagnostics-based services. Its cancer genome diagnostic platform include The NEO Technology, NEOplus and NEOliquid which support pathologists and oncologists with comprehensive molecular information to help select targeted cancer therapies. The company was founded by Roman Thomas and Axel Ullrich in 2012 and is headquartered in Cologne, Germany. | Chief Executive Officer | - |
Evotec (München) GmbH
 Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The private company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | Chief Executive Officer | - |
Opleiding van Andreas Jenne
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The private company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | Process Industries |
RSP Systems A/S
RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark | Health Technology |
NEO New Oncology GmbH
NEO New Oncology GmbH Medical/Nursing ServicesHealth Services NEO New Oncology GmbH provides molecular diagnostics-based services. Its cancer genome diagnostic platform include The NEO Technology, NEOplus and NEOliquid which support pathologists and oncologists with comprehensive molecular information to help select targeted cancer therapies. The company was founded by Roman Thomas and Axel Ullrich in 2012 and is headquartered in Cologne, Germany. | Health Services |
SciRhom GmbH
SciRhom GmbH Miscellaneous Commercial ServicesCommercial Services SciRhom GmbH engages in the development of treatment for life-threatening diseases. The company was founded by Andreas Jenne, Jens Ruhein, Axel Ullrich, Carl Blobel and Matthias Schneider in 2016 and is headquartered in Planegg, Germany. | Commercial Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Finance |
